Advances in Drug Discovery Processes

This session welcomes abstracts addressing the latest advances in processes that enable small molecule drug discovery. Examples would be inclusive of methodology for library generation through to lead molecule identification/generation and any subsequent scaling initiatives. Scientists involved in all aspects of drug discovery, be it computational or synthetic are invited. Topics may include, but not limited to, high-through put screening platforms, computational techniques for retrosynthetic analysis or reaction outcome prediction, synthesis platforms (automated or manual), novel bond formations thorough methodology development, and separation/purification techniques.